Ignite Creation Date:
2024-05-06 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05154994
Status:
SUSPENDED
Last Update Posted:
2024-06-18
First Post:
2021-11-30
Brief Title:
Tremelimumab DurvalumabMEDI4736 Belinostat in ARID1A Mutated Cancer Focus on Urothelial Carcinoma
Sponsor:
University of Utah
Organization:
University of Utah
Organization Data
Organization:
University of Utah
Class:
OTHER
Study ID:
HCI143952
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Utah
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |